Background: Using fluorescently labeled superoxide dismutase (SOD) and flow cytometry, we have shown previously that the enzyme CuZn SOD (EC 1.15.1.1) from bovine erythrocytes binds rapidly to the cell surface with slow uptake into the cell during the following hours. The degree of labeling was most important for monocytes in comparison to other blood cells (erythrocytes, lymphocytes, and neutrophils) and fibroblasts. In agreement with the flowcytometric findings, the inhibition of superoxide production was more important for SOD-pretreated monocytes than for neutrophils, as demonstrated with the cytochrome c reduction assay. It was thus of interest to confirm the observed differences between monocytes and neutrophils with confocal laser microscopy, study in greater detail the kinetics of binding, penetration, and intracellular localization of the enzyme, and compare the results obtained with bovine CuZn SOD with those from SODs of other origins and carrying different active sites. Materials and Methods: Recombinant human (rh), bovine, and equine CuZn SODs, as well as rh and E. coli Mn SODs, were studied before use with respect to specific activity and purity (HPLC, SDS-PAGE electrophoresis). Fluorescein isothiocyanate was covalently conjugated to the various SODs for study with high-resolution confocal scanning laser microscopy. Superoxide production by monocytes and neutrophils was measured with the cytochrome c assay. Results: As expected from our experiments with flow cytometry, only rare neutrophils were labeled with FITC-SOD, even with the longest incubation time of 3 hr and the
Introduction
Soon after the discovery of superoxide dismutase (SOD, EC 1.15.1.1) in 1969 (1), the enzyme was tested for its therapeutic efficacy in free radicalrelated disorders (2) (3) (4) (5) . Its beneficial effects were questioned, however, because of the rapid clearance of the enzyme from the bloodstream. Despite several reports indicating intracellular penetration (6-9), many scientists remained convinced that SOD action was limited to the extracellular space.
Using fluorescently labeled bovine CuZn SOD and flow cytometry, we have shown previously that the enzyme binds rapidly to the cells (10) . The degree of labeling was concentrationdependent and most important for monocytes in comparison to other blood cells (erythrocytes, lymphocytes, and neutrophils) and human skin fibroblasts. In agreement with the flow-cytometric findings, the cytochrome c assay showed significantly diminished 02 production by monocytes pretreated with SOD and washed thereafter, whereas pretreatment of neutrophils with the same enzyme concentrations and incubation times did not result in significant inhibition of O2.-production. Another interesting finding was the persistence of the anticlastogenic effects of CuZn SOD after intensive washing of the cells (10) . Removal of all extracellular SOD was ascertained by activity measurements in the cell culture medium. This work also included preliminary studies with confocal laser microscopy in monocytes, which showed that the CuZn SOD binds rapidly (15 min) to the cell surface of monocytes, but that the fluorescence becomes visible in the cytoplasm only after 1 hr. No fluorescence was seen at the nuclear level.
Since all these studies were carried out with CuZn SOD extracted from bovine erythrocytes, it was important to confirm whether the observations described above are also true for SODs of other origins.
Materials and Methods

Enzymes
CuZn SOD from bovine and horse erythrocytes were obtained from Palleau Production (Chateau-Landon, France). Manganese SOD from E. coli and bovine CuZn SOD for comparative studies were purchased from Sigma (St. Louis, MO). Recombinant human (rh) CuZn and Mn SOD were a gift from Bio-Technology General (BTG) Ltd (Rehovot, Israel). Catalase from bovine liver was obtained from Sigma.
All SODs were studied before use for specific activity and purity. The activity was assayed through the reduction of cytochrome c by superoxide generated with a xanthine-xanthine oxidase reaction (1) . The protein content of the samples was measured according to Lowry et al. (11) . The purity of the enzymes was studied by high-performance liquid chromatography (HPLC) and polyacrylamide gel electrophoresis (PAGE 
SDS-PAGE
Electrophoretic separation by SDS-PAGE was performed in a Pharmacia apparatus with a 0.5-mm-thick 7.5% polyacrylamide gel for horizontal electrophoresis as described by Laemmli (12) . The gels were silver stained according to Heukeshover and Dernick (13 
Results
Specific Activity and Purity of Different SODs Used in This Study
The specific activities of the various SODs are shown in Table 1 . Bovine and equine CuZn SOD from Palleau Production had the highest specific activity, followed by rh CuZn SOD from BTG and bovine CuZn SOD from Sigma. The lowest specific activity was noted for the Mn enzymes from BTG and Sigma. The influence of FITC-labeling on enzyme activity was studied in parallel experiments with labeled and native SODs. The reduction in activity varied between 9% and 20% after elution from the Sephadex column under identical conditions. This loss was taken into account for the experiments with FITC-labeled SODs.
With the injection of aliquots containing equal numbers of activity units, HPLC chromatograms were quite similar for all CuZn SODs, with one major peak. The Mn enzymes showed minor peaks corresponding to protein contamination.
Given the same quantity of protein, only one minor additional band for the bovine, human, and horse SODs was detected through electrophoresis. The purity evaluated by scanner was about 98%. The major band corresponded to their molecular weight of 32 kD. The Mn SOD from E. coli showed multiple minor bands in addition to the main band corresponding to a molecular weight of 39 kD, purity 77% (Fig. 1) .
Detection of FITC-SOD by Confocal Laser Microscopy COMPARISON OF LYMPHOCYTES, MONOCYTES, AND
NEUTROPHILS. In agreement with the results obtained in our previous study by flow cytometry (10), lymphocytes from different donors did not show any fluorescent labeling even after an incubation time of 3 hr with doses of 1500 units/ ml. This was true not only for unstimulated lymphocytes but also for lymphoblasts studied after 48 hr of phytohemagglutinin (PHA) stimulation.
Also as expected from our experiments with flow cytometry, only rare neutrophils were labeled with FITC-SOD, despite the use of a maximal incubation time of 3 hr and the highest dose (1500 units/ml). The fluorescence pattern was different from that of monocytes, focalized in a single, very intense spot (Fig. 2) .
In contrast to lymphocytes and neutrophils, monocytes regularly had a diffuse fluorescence pattern, as in our previous study. This was seen after FITC-SOD pretreatment only, not in untreated monocyte layers.
COMPARISON OF DIFFERENT SODS ON MONOCYTES.
The various types of SOD were compared using identical activity (150 and 1500 units/ml) or identical quantities of protein.
At identical activity, the intracellular distribution of the fluorescently labeled SODs was similar for the two bovine CuZn SODs and the horse SOD, and was visible on the membrane, in the cytoplasm, and around the nucleus as a function of incubation time. As in our previous study, numerous monocytes showed green fluorescence on the surface after an incubation time of only 15 min. Even 5 min of incubation at 1500 units/ml was sufficient to obtain labeled cells at low frequency (about 1 for 1000 cells). The intensity of the labeling and the frequency of labeled cells was less important with the lower dose of 150 units/ml (Table 1 and Fig. 2) . As ascertained by focusing through the cell, the fluorescence was never located at the nuclear level. An example of 1-gm-thick confocal sections is shown in Figure 2 . For the human enzyme, no perinuclear accumulation was seen after an exposure time of 3 hr with the lower dose of 150 units/ml, whereas fluorescence throughout the cell, including perinuclear localization, was observed with the dose of 1500 units/ml. For both Mn SODs, the number of fluorescent cells was very low. Therefore, the intracellular distribution of fluorescence and its pattern was difficult to determine. In the rare cells labeled with Mn SOD from E. coli, the pattern was spotty, similar to the pattern in neutrophils (Fig. 2, Table 2 ). No difference in the inhibitory effect was observed between native and FITC-modified SOD at equal concentrations (Table 2 ).
In three other experiments, superoxide production by monocytes was measured after a short incubation time of 5 min, when no intracellular SOD was detectable with confocal laser microscopy (bovine CuZn SOD 1500 units/ml). The incubation time with cytochrome c was reduced to 20 min for these experiments to exclude penetration of the enzyme during the assay period. Cytochrome c reduction was inhibited by 46%, 43%, and 31%, respectively for the three assays.
Discussion
The results obtained here through confocal laser microscopy indicate that not only 15 Dini and Rotilio (8) , who also demonstrated intracellular uptake in the liver after intraperitoneal injection of SOD (17) . In vivo studies carried out by Sahgal et al. (18) in newborn piglets showed that after intratracheal administration, rh CuZn SOD could be demonstrated by confocal laser microscopy in a variety of cell types of airways, respiratory bronchioles, and alveoli, significantly increasing lung SOD activity. The mechanisms involved in the uptake of SOD are still subject to debate. Two such mechanisms, receptor-mediated endocytosis and fluid-phase endocytosis, have been considered (9) . While uptake via receptor-mediated endocytosis requires the binding of the ligand to a specific cell surface receptor, fluid-phase endocytosis is a nonsaturable receptor-independent process. Inside the cell, the SOD was supposed to be located in endosomes and lysosomes (16, 17) . Intranuclear localization of exogenous SODs was not reported. Also in the present study, no fluorescence in the nuclear compartment could be detected by confocal laser microscopy, even if a long incubation time of 3 hr at a high concentration of 1500 units/ml was used, perinuclear accumulation of the FITC-SOD was observed with time. The remaining fluorescence on the membrane and in the more peripheral cytoplasmic areas suggests a unidirectional intracellular migration from the cellular to the nuclear membrane, which appears to be a barrier for further progression. The absence of detectable nuclear FITC fluorescence is in agreement with the findings of Petkau et al. (19) , who studied uptake of There is no nuclear labeling. (8) (20) . The SOD may have been degraded after incorporation of the label into larger proteins. This would explain why the label did not appear in the nuclear compartment. However, this hypothesis does not explain the striking perinuclear accumulation of the punctate labeling pattern in the monocytes.
Whether intracellular uptake of SOD is necessary for its protective action is another subject of controversy. While Kyle et al. (9) conclude that intracellular uptake of SOD is required for its protective effects, others think that binding to the membrane is sufficient for protection against free radical attack (7, 21, 22) . Inhibition of superoxide production of membrane-bound SOD may be due to efficient dismutation of superoxide radicals on the outer surface of the cell membrane, since the active site of NADPH oxidase faces the outside of the cell membrane, and there may remain enough SOD at the membrane for dismutation of superoxide, even after 3 hr. Our results obtained with the cytochrome c assay indicate diminished superoxide release after an incubation period with SOD of only 5 min, when FITC-SOD was detected only on the membrane, not in the cytoplasm, by confocal laser microscopy. In our opinion, the discussions about whether exogenous SOD is protective extracellularly, intracellularly, or on the membrane level are not the heart of the matter, since any of these localizations of SOD may be protective, depending on the biological site of oxidative stress.
Most studies in the literature concerning cellular penetration of SOD have been done with the CuZn enzymes, as was the case in our previous report (10) . The principal aim of the present study was to compare SODs of various origins and active sites in the monocyte model. Bovine CuZn SODs from two different manufacturers, as well as horse CuZn SOD, showed quite similar penetration and intracellular distribution. Minor differences were observed in simultaneous experiments on the same cells with the lowest activity of rh CuZn SOD, where the number of labeled cells was less important. Penetration and intracellular distribution also appeared to be delayed, since there was no perinuclear accumulation.
The most important finding of this study, however, is the difference between CuZn and Mn SODs. Both Mn SOD from E. coli and rh Mn SOD showed poor binding capacity in parallel comparative experiments with CuZn SODs. Despite the fact that rh CuZn and rh Mn SOD were prepared by the same manufacturer (BTG), binding and penetration were quite different. The observations under the confocal laser microscope were in agreement with differences in the cytochrome c assay, which showed a weak inhibitory effect on superoxide production by the two Mn SODs. This difference was observed with FITClabeled and native SODs. The reasons for these discrepancies between SODs with different active sites are not clear. Differences in electrostatical charges may be responsible, since it has been shown that SODs with a higher pI have a higher affinity to the membrane than others (23) .
The findings reported here are of interest from a medical and therapeutic standpoint. We show that SOD binds to the cell membrane after only 5 min. This may explain the reports of SOD's beneficial effects despite the rapid clearance of the enzyme following intravenous injection. The preferential binding of exogenous CuZn SOD to monocytes compared to neutrophils may explain why therapeutic effects of SOD have been reported mainly for chronic inflammatory diseases, in particular rheumatoid arthritis, in which the monocytes are in an activated state and exhibit increased superoxide production (24) . Further studies are necessary to determine whether the differences observed between CuZn SODs and Mn SODs, as well for binding capacity and inhibition of PMA-stimulated superoxide production by monocytes, are also reflected in the therapeutic efficacy of these enzymes.
